Clinical Trial Update: A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating SM04554 topical solution for efficacy and safety in male androgenetic alopecia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• SM04554 Topical Solution (SM04554 topical solution)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Androgenetic Alopecia | Phase 2, Phase 3 | Status: COMPLETED